Elisa Postorino Selected Research

clobetasone butyrate (Eumovate)

5/2013

Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sjögren syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Postorino Research Topics

Disease

3	Dry Eye Syndromes (Dry Eye Syndrome) 01/2018 - 05/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Parkinson Disease (Parkinson's Disease) 12/2017
1	Inflammation (Inflammations) 01/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2018 - 12/2017
2	Ophthalmic Solutions (Eye Drops)IBA 01/2015 - 05/2013
1	secukinumabIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Loteprednol Etabonate (Alrex)FDA Link 01/2015
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	InterferonsIBA 01/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	clobetasone butyrate (Eumovate)IBA 05/2013

Therapy/Procedure

1	Therapeutics 05/2013